Booster Dose (India)
This article was originally published in PharmAsia News
Executive Summary
Drug research and development is on the brink of being revolutionized by a new data-mining process known as chemoinformatics. A number of Indian pharmaceutical companies including Dr. Reddy's Laboratories, Wockhardt, Sun Pharma, Nicholas Piramal, and Ranbaxy are already beginning to take advantage of this technique. In chemoinformatics, researchers use computer software to create and search lists of thousands of chemical compounds. Scientists can then identify molecular combinations that are most promising for further development into new drugs. This technique can also help eliminate molecules with possibly toxic properties. By speeding up the chemical selection process, Indian drug manufacturers hope to gain the advantage over stiff international and generic competition. (Click here for more